MYC upregulation is linked to IMiD resistance [11], and CRBN aberrations, including acquired mutations of CRBN and associated genes, have been reported in a subset (22%) of IMiD-resistant MM patients [12,13]. The gene discussed is CRBN; the disease is Miyoshi myopathy.